EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis

Arja Ray iD, Kenneth H Hu iD, Kelly Kersten iD, Tristan Courau iD, Nicholas F Kuhn iD, Itzia Zaleta-Linares iD, Bushra Samad iD, Alexis J Combes iD, Matthew F Krummel iD

Journal of Experimental Medicine · 06.01.2025 · 222 (1)

DOI: 10.1084/jem.20240957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 27.11.2024. Verfasst von Arja Ray und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Killer Cells, Natural, Lectins, C-Type, Receptors, Cell Surface. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NCI NIH HHS, Jean Perkins Foundation, Cancer Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD206 is a common marker of a putative immunosuppressive “M2” state in tumor-associated macrophages (TAMs). We made a novel conditional CD206 (Mrc1) knock-in mouse to specifically visualize and/or deplete CD206+ TAMs. Early depletion of CD206+ macrophages and monocytes (Mono/Macs) led to the indirect loss of conventional type I dendritic cells (cDC1), CD8 T cells, and NK cells in tumors. CD206+ TAMs robustly expressed CXCL9, contrasting with stress-responsive Spp1-expressing TAMs and immature monocytes, which became prominent with early depletion. CD206+ TAMs differentially attracted activated CD8 T cells, and the NK and CD8 T cells in CD206-depleted tumors were deficient in Cxcr3 and cDC1-supportive Xcl1 and Flt3l expressions. Disrupting this key antitumor axis decreased tumor control by antigen-specific T cells in mice. In human cancers, a CD206Replete, but not a CD206Depleted Mono/Mac gene signature correlated robustly with CD8 T cell, cDC1, and NK signatures and was associated with better survival. These findings negate the unqualified classification of CD206+ “M2-like” macrophages as immunosuppressive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesKiller Cells, NaturalLectins, C-TypeReceptors, Cell SurfaceMacrophagesAnimalsMiceHumansDendritic CellsMannose ReceptorMice, Inbred C57BLMannose-Binding LectinsReceptors, CXCR3Chemokine CXCL9Tumor-Associated MacrophagesMembrane GlycoproteinsNeoplasmsGene Knock-In TechniquesReceptors, ImmunologicMonocytesReceptors, Chemokine

Substanzen

Lectins, C-TypeReceptors, Cell SurfaceMannose ReceptorMannose-Binding LectinsReceptors, CXCR3Chemokine CXCL9Cxcr3 protein, mouseMRC1 protein, humanMembrane GlycoproteinsReceptors, Immunologic

Autor:innen und Institutionen

  • Department of Pathology, University of California, San Francisco, CA, USA.
  • ImmunoX Initiative, University of California, San Francisco, CA, USA.
  • UCSF CoLabs, University of California, San Francisco, CA, USA.
  • Department of Medicine, University of California, San Francisco, CA, USA.

ORCID-Profile: Arja Ray, Kenneth H Hu, Kelly Kersten, Tristan Courau, Nicholas F Kuhn, Itzia Zaleta-Linares, Bushra Samad, Alexis J Combes, Matthew F Krummel

Förderung

  • NCI NIH HHS
  • Jean Perkins Foundation
  • Cancer Research Institute
  • NIH HHS
  • American Cancer Society
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Ray, A., Hu, K. H., Kersten, K., Courau, T., Kuhn, N. F., Zaleta-Linares, I., Samad, B., Combes, A. J., & Krummel, M. F. (2025). Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis. Journal of Experimental Medicine, 222(1). https://doi.org/10.1084/jem.20240957

Vancouver

Ray A, Hu KH, Kersten K, Courau T, Kuhn NF, Zaleta-Linares I, et al. Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis. Journal of Experimental Medicine. 2025;222(1). doi:10.1084/jem.20240957

BibTeX
@article{Ray2025,
  author = {Ray, Arja and Hu, Kenneth H and Kersten, Kelly and Courau, Tristan and Kuhn, Nicholas F and Zaleta-Linares, Itzia and Samad, Bushra and Combes, Alexis J and Krummel, Matthew F},
  title = {Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  volume = {222},
  number = {1},
  doi = {10.1084/jem.20240957}
}
Kostenlos starten →